Alcohol: what moderate drinking actually means in 2026

For decades, the medical consensus was that moderate alcohol consumption — one glass of red wine per day — was protective for heart health. It was one of the few vice-as-medicine stories that seemed too good to be true. In 2026, we can say with confidence: it was.

How the old evidence misled us

The "moderate drinking is healthy" narrative was based on observational studies that consistently found a J-shaped curve: non-drinkers had higher mortality than moderate drinkers, with heavy drinkers having the highest risk. The interpretation seemed straightforward — a glass of wine a day keeps the doctor away.

The problem was a fundamental methodological flaw called abstainer bias. The "non-drinker" group in these studies included people who had quit drinking due to illness, people on medications incompatible with alcohol, and people with health conditions that prevented them from drinking. These weren't healthy abstainers — they were sick people who couldn't drink. Comparing them to healthy moderate drinkers made alcohol look protective when it wasn't.

When researchers corrected for this bias — most notably in a landmark 2023 meta-analysis in JAMA Network Open covering 107 studies and nearly 5 million participants — the J-curve disappeared. There was no protective effect of moderate drinking. The risk started at zero drinks and increased linearly with consumption.

The Global Burden of Disease study (2018, updated 2023) was unequivocal: the level of alcohol consumption that minimizes overall health risk is zero.

What alcohol actually does to your body

Even at "moderate" levels (1–2 drinks per day), alcohol has measurable effects on several systems we assess in our program:

• Liver: GGT is the most sensitive liver enzyme for alcohol exposure. Even 1 drink per day can elevate GGT above optimal levels. ALT may follow with sustained consumption.
• Cancer: Alcohol is classified as a Group 1 carcinogen by the WHO. Even moderate consumption increases risk of breast cancer (7% per drink per day), colorectal cancer, and esophageal cancer.
• Cardiovascular: While low-dose alcohol may slightly reduce coronary events, this is more than offset by increased risk of atrial fibrillation, hemorrhagic stroke, and cardiomyopathy.
• Metabolic: Alcohol impairs insulin sensitivity, increases triglycerides, contributes to visceral fat accumulation, and disrupts sleep architecture — even when you think it helps you sleep.
• Sleep: Alcohol is a sedative, not a sleep aid. It reduces REM sleep, increases sleep fragmentation, and worsens sleep apnea. The subjective feeling of sleeping better after a drink is physiologically wrong.

Why this matters for executives specifically

Executive culture normalizes regular alcohol consumption — business dinners, networking events, client entertainment, travel. A pattern of 2–3 drinks several nights per week is common and socially unremarkable. But it's not metabolically unremarkable.

In our DETECT panel, we frequently see the fingerprints: mildly elevated GGT, triglycerides above optimal, disrupted sleep patterns, elevated uric acid. Each of these individually might be dismissed. Together, they form a pattern that often points to one thing — and it's usually not what the patient expects to hear.

The bottom line: if you drink, understand that the old "one glass is good for you" story is dead. There's no health benefit at any dose. There may be quality-of-life benefits that you value — and that's a legitimate personal choice. But make it with accurate information, not outdated science.